199 related articles for article (PubMed ID: 19766715)
1. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy.
Eriksson SE; Prast-Nielsen S; Flaberg E; Szekely L; Arnér ES
Free Radic Biol Med; 2009 Dec; 47(11):1661-71. PubMed ID: 19766715
[TBL] [Abstract][Full Text] [Related]
2. Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase.
Peng X; Xu J; Arnér ES
Biochem J; 2012 Oct; 447(1):167-74. PubMed ID: 22784015
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lung cancer cells with cytotoxic levels of sodium selenite: effects on the thioredoxin system.
Selenius M; Fernandes AP; Brodin O; Björnstedt M; Rundlöf AK
Biochem Pharmacol; 2008 Jun; 75(11):2092-9. PubMed ID: 18405881
[TBL] [Abstract][Full Text] [Related]
4. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
5. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
Prast-Nielsen S; Cebula M; Pader I; Arnér ES
Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
[TBL] [Abstract][Full Text] [Related]
6. Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift.
Rigobello MP; Gandin V; Folda A; Rundlöf AK; Fernandes AP; Bindoli A; Marzano C; Björnstedt M
Free Radic Biol Med; 2009 Sep; 47(6):710-21. PubMed ID: 19486940
[TBL] [Abstract][Full Text] [Related]
7. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2.
Sakurai A; Nishimoto M; Himeno S; Imura N; Tsujimoto M; Kunimoto M; Hara S
J Cell Physiol; 2005 Jun; 203(3):529-37. PubMed ID: 15521073
[TBL] [Abstract][Full Text] [Related]
9. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia.
Talbot S; Nelson R; Self WT
Br J Pharmacol; 2008 Jul; 154(5):940-8. PubMed ID: 18587442
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of thioredoxin reductase 1 in human oral squamous cell carcinoma.
Iwasawa S; Yamano Y; Takiguchi Y; Tanzawa H; Tatsumi K; Uzawa K
Oncol Rep; 2011 Mar; 25(3):637-44. PubMed ID: 21206984
[TBL] [Abstract][Full Text] [Related]
12. [Effects of hnRNP B1 on DNA-PK activity, cell cycle and apoptosis in human lung adenocarcinoma cell line A549].
Han J; Li WM; Tang FM; Pu D; Chen WB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):815-8. PubMed ID: 19024322
[TBL] [Abstract][Full Text] [Related]
13. Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductase.
Xu J; Arnér ES
Biochem Pharmacol; 2012 Mar; 83(6):815-20. PubMed ID: 22226931
[TBL] [Abstract][Full Text] [Related]
14. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
[TBL] [Abstract][Full Text] [Related]
15. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
16. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
[TBL] [Abstract][Full Text] [Related]
18. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin reductase 1 upregulates MCP-1 release in human endothelial cells.
Liu ZB; Shen X
Biochem Biophys Res Commun; 2009 Sep; 386(4):703-8. PubMed ID: 19555664
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.
Marzano C; Gandin V; Folda A; Scutari G; Bindoli A; Rigobello MP
Free Radic Biol Med; 2007 Mar; 42(6):872-81. PubMed ID: 17320769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
